PRDM1 and Miyoshi myopathy: LSD1 also modulates PB transcriptional networks by regulating chromatin accessibility and methylation level on several enhancers and PU.1, IRF4, and Blimp-1 binding sites, leading to the activation of key factors of MM pathogenesis, including c-MYC [45].